We are pleased to announce the launch of Accel-Heal Solo in the Nordic region and are delighted to partner with OneMed, a leading supplier of innovative wound solutions across the Nordic region. The exclusive agreement covers Denmark, Sweden, Norway and Finland.
With OneMed, we look forward to showcasing Accel-Heal Solo at the Danish Wound Healing Society on the 21st and 22nd of November in Kolding and discussing the use of this therapy with Nordic wound care leaders.
About Accel-Heal Technologies Limited
Accel-Heal Technologies Limited is a UK-based wound care company who are passionate about enabling more patients to benefit from the strongly evidence based, microcurrent electrical stimulation therapy (EST). Accel-Heal Solo is an easy-to-use electrical stimulation device for hard-to-heal wounds which relieves pain and stimulates healing. A small, wearable device, Accel-Heal provides advanced 12-day therapy in a simple way that can be managed by patients or carers at home. For more details on the use of Accel-Heal please visit accelheal.com
About OneMed
OneMed is a distributor of medical device in the northern countries and all are part of Asker Healthcare Group who is a partner to caregivers and patients across Europe providing medical products and solutions. We build and acquire leading companies that together support the healthcare system to improve patient outcomes, reduce total cost of care and ensure a fair and sustainable value chain. We are a European healthcare group that combines the entrepreneurial drive of strong local companies, with the abilities and collected knowledge of a large group – driving progress in the healthcare sector. The group has 4 000 employees in 17 countries and revenues amounting to SEK 15 billion (approx. £1 billion).